Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 21;13(12):e081134.
doi: 10.1136/bmjopen-2023-081134.

Behavioural and social drivers of COVID-19 vaccination in Vietnam: a scoping review

Affiliations

Behavioural and social drivers of COVID-19 vaccination in Vietnam: a scoping review

Luong Tran et al. BMJ Open. .

Abstract

Background: Understanding of the behavioural and social drivers (BeSD) of vaccination is key to addressing vaccine hesitancy and accessibility issues. Vietnam's national COVID-19 vaccination programme resulted in high uptake of primary doses among adults, but lower booster doses for adults and primary doses for 5-11 years. This scoping review assessed BeSD influencing COVID-19 vaccine uptake in Vietnam to design interventions on reaching the national vaccination targets.

Method: We conducted a scoping review by searching PubMed, MedRxiv, LitCOVID, COVID-19 LOVE platform, WHO's COVID-19 research database and seven dominant Vietnamese language medical journals published in English or Vietnamese between 28 December 2019 and 28 November 2022. Data were narratively synthesised and summarised according to the four components of the WHO BeSD framework. The drivers were then mapped along the timeline of COVID-19 vaccine deployment and the evolution of the pandemic in Vietnam.

Results: We identified 680 records, of which 39 met the inclusion criteria comprising 224 204 participants. Adults' intention to receive COVID-19 vaccines for themselves (23 studies) ranged from 58.0% to 98.1%. Parental intention to vaccinate their under 11-year-old children (six studies) ranged from 32.8% to 79.6%. Key drivers of vaccination uptake were perceived susceptibility and severity of disease, perceived vaccine benefits and safety, healthcare worker recommendation, and positive societal perception. Commonly reported COVID-19 vaccines' information sources (six studies) were social and mainstream media (82%-67%), television (72.7%-51.6%) and healthcare workers (47.5%-17.5%). Key drivers of COVID-19 uptake remained consistent for both adults and children despite changes in community transmission and vaccine deployment.

Conclusion: Key enablers of vaccine uptake for adults and children included perceived disease severity, perceived vaccine benefits and safety and healthcare worker recommendations. Future studies should assess vaccine communication targeted to these drivers, national policies and political determinants to optimise vaccine uptake.

Keywords: COVID-19; SARS-CoV-2 Infection; Vaccination.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
PRISMA flow chart of search strategy and selection of studies for inclusion in the scoping review. *COVID-19 research resource by WHO, **The United Nations Children’s Fund, ***Centre for Creative Initiatives in Health and Population. PRISMA, Preferred Reporting Items for Systemic Reviews and Meta-Analyses.
Figure 2
Figure 2
A summary of key social and behavioural drivers of COVID-19 uptake.
Figure 3
Figure 3
Reported intention to get vaccinated and the confidence in vaccine benefits among adults along with the timeline of COVID-19 pandemic. The rates of adults’ intention to vaccinate and their confidence in the benefits of vaccines were reported in the included studies. The cumulative incidence of COVID-19 cases reported during the study period was extracted from reports by the WHO (COVID-19 Vietnam Situation Report).

Similar articles

Cited by

References

    1. Steinert JI, Sternberg H, Prince H, et al. . COVID-19 vaccine hesitancy in eight European countries: prevalence, determinants, and heterogeneity. Sci Adv 2022;8:eabm9825. 10.1126/sciadv.abm9825 - DOI - PMC - PubMed
    1. Rahmani K, Shavaleh R, Forouhi M, et al. . The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: a systematic review and meta-analysis. Front Public Health 2022;10:873596. 10.3389/fpubh.2022.873596 - DOI - PMC - PubMed
    1. Total COVID-19 vaccine doses administered. England and Wales: Our World in Data; 2023. Available: https://ourworldindata.org/grapher/cumulative-COVID-vaccinations [Accessed 29 Mar 2023].
    1. Watson OJ, Barnsley G, Toor J, et al. . Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis 2022;22:1293–302. 10.1016/S1473-3099(22)00320-6 - DOI - PMC - PubMed
    1. Kaufman J, Tuckerman J, Danchin M. Overcoming COVID-19 vaccine hesitancy: can Australia reach the last 20 percent Expert Rev Vaccines 2022;21:159–61. 10.1080/14760584.2022.2013819 - DOI - PubMed

Publication types

Substances